Sarepta Therapeutics Inc (SRPT)
116.51
-1.38
(-1.17%)
USD |
NASDAQ |
Apr 18, 16:00
116.52
+0.01
(+0.01%)
Pre-Market: 20:00
Sarepta Therapeutics Price: 116.51 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 117.55 | 118.90 | 115.79 | 116.51 | 450661.0 |
| Apr 17, 2024 | 117.00 | 119.08 | 115.93 | 117.89 | 546229.0 |
| Apr 16, 2024 | 117.60 | 118.69 | 116.94 | 117.29 | 592917.0 |
| Apr 15, 2024 | 122.18 | 122.98 | 117.78 | 118.31 | 860486.0 |
| Apr 12, 2024 | 124.17 | 124.82 | 121.49 | 122.87 | 656117.0 |
| Apr 11, 2024 | 127.28 | 127.49 | 123.40 | 124.45 | 618223.0 |
| Apr 10, 2024 | 124.13 | 126.47 | 123.87 | 126.31 | 523340.0 |
| Apr 09, 2024 | 126.46 | 127.41 | 126.07 | 126.98 | 286092.0 |
| Apr 08, 2024 | 126.17 | 126.68 | 124.37 | 126.39 | 559199.0 |
| Apr 05, 2024 | 125.43 | 127.64 | 123.85 | 126.08 | 303511.0 |
| Apr 04, 2024 | 127.22 | 128.23 | 124.87 | 125.79 | 747118.0 |
| Apr 03, 2024 | 126.07 | 128.60 | 125.17 | 126.92 | 851048.0 |
| Apr 02, 2024 | 127.68 | 128.80 | 125.80 | 127.00 | 519194.0 |
| Apr 01, 2024 | 129.38 | 129.38 | 126.11 | 128.40 | 858391.0 |
| Mar 28, 2024 | 131.16 | 131.16 | 127.83 | 129.46 | 811626.0 |
| Mar 27, 2024 | 129.25 | 130.32 | 127.36 | 130.23 | 592604.0 |
| Mar 26, 2024 | 129.83 | 129.97 | 128.00 | 128.25 | 530108.0 |
| Mar 25, 2024 | 127.00 | 128.95 | 126.00 | 127.94 | 396054.0 |
| Mar 22, 2024 | 125.14 | 128.19 | 124.74 | 127.54 | 628292.0 |
| Mar 21, 2024 | 126.98 | 128.44 | 124.27 | 124.94 | 458091.0 |
| Mar 20, 2024 | 124.37 | 126.11 | 122.72 | 126.08 | 551513.0 |
| Mar 19, 2024 | 123.80 | 125.60 | 122.65 | 124.06 | 811173.0 |
| Mar 18, 2024 | 123.72 | 125.41 | 122.33 | 123.97 | 523125.0 |
| Mar 15, 2024 | 123.49 | 125.24 | 121.60 | 123.05 | 1.246M |
| Mar 14, 2024 | 121.17 | 125.00 | 120.58 | 123.76 | 644210.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
108.99
Average
111.44
Median
Price Benchmarks
| CytomX Therapeutics Inc | 1.73 |
| PTC Therapeutics Inc | 24.70 |
| Vertex Pharmaceuticals Inc | 393.48 |
| Puma Biotechnology Inc | 4.99 |
| Regenxbio Inc | 16.11 |
Price Related Metrics
| PS Ratio | 8.658 |
| Price to Book Value | 12.72 |
| Earnings Yield | -5.00% |
| Market Cap | 10.94B |